Instil Bio, Inc. Profile Avatar - Palmy Investing

Instil Bio, Inc.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline includ…

Biotechnology
US, Dallas [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Instil Bio, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Instil Bio, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Instil Bio, Inc..

End of TIL's Analysis
CIK: 1789769 CUSIP: 45783C101 ISIN: US45783C2008 LEI: - UEI: -
Secondary Listings
TIL has no secondary listings inside our databases.